AdvanSix Inc. (NYSE:ASIX - Get Free Report) traded down 0.9% during mid-day trading on Thursday . The company traded as low as $31.55 and last traded at $31.62. 80,031 shares traded hands during trading, a decline of 43% from the average session volume of 141,588 shares. The stock had previously closed at $31.91.
Wall Street Analyst Weigh In
ASIX has been the topic of a number of research reports. StockNews.com lowered shares of AdvanSix from a "buy" rating to a "hold" rating in a research note on Tuesday, November 19th. Piper Sandler boosted their price objective on shares of AdvanSix from $35.00 to $39.00 and gave the company an "overweight" rating in a research report on Friday, November 8th.
View Our Latest Stock Report on AdvanSix
AdvanSix Price Performance
The company has a current ratio of 1.34, a quick ratio of 0.62 and a debt-to-equity ratio of 0.28. The company has a 50 day simple moving average of $30.13 and a 200 day simple moving average of $27.20. The stock has a market cap of $845.23 million, a P/E ratio of 22.43 and a beta of 1.69.
AdvanSix Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.02%. The ex-dividend date of this dividend was Tuesday, November 12th. AdvanSix's dividend payout ratio is presently 45.39%.
Insider Buying and Selling
In related news, Director Donald P. Newman acquired 5,030 shares of the company's stock in a transaction dated Monday, November 18th. The shares were bought at an average price of $29.64 per share, for a total transaction of $149,089.20. Following the purchase, the director now directly owns 5,030 shares in the company, valued at approximately $149,089.20. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Erin N. Kane sold 5,000 shares of the stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $30.28, for a total value of $151,400.00. Following the completion of the sale, the chief executive officer now directly owns 522,795 shares of the company's stock, valued at approximately $15,830,232.60. The trade was a 0.95 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,369 shares of company stock worth $474,058. 5.60% of the stock is owned by insiders.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the company. Copeland Capital Management LLC acquired a new position in shares of AdvanSix during the 3rd quarter worth approximately $41,000. Point72 DIFC Ltd bought a new position in AdvanSix during the second quarter worth $34,000. Acadian Asset Management LLC acquired a new position in shares of AdvanSix in the second quarter valued at $36,000. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of AdvanSix in the second quarter valued at about $51,000. Finally, Allspring Global Investments Holdings LLC acquired a new stake in shares of AdvanSix during the 2nd quarter worth about $51,000. 86.39% of the stock is currently owned by institutional investors and hedge funds.
AdvanSix Company Profile
(
Get Free Report)
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
Featured Stories
Before you consider AdvanSix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdvanSix wasn't on the list.
While AdvanSix currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.